“躺平”了!英國首相宣佈與新冠共存,將解除所有防控措施,包括陽性患者,鍾南山談香港疫情:我們不會容忍自然感染導致大量的長者死亡
面對新冠病毒的侵襲,有些國家選擇了“躺平”,有些國家繼續抗爭。
當地時間2月21日,英國首相鮑裏斯·約翰遜宣佈,自2月24日起,將解除英格蘭地區所有疫情防控措施,正式開始“與新冠共存”計劃。
計劃的具體措施包括新冠檢測呈陽性的患者將無需依法隔離;針對普通公衆有症狀和無症狀患者的免費檢測將於4月1日取消,免費檢測將僅針對於脆弱羣體。
約翰遜還表示,英國是時候將疫情由“政府幹預”層面轉爲“個人責任”層面。這也意味着英國和一些國家一樣選擇通過羣體免疫的方式來戰勝病毒。
國內:爭取動態清零
國外疫情嚴重,中國國內的疫情也不容放鬆。2月21日,根據香港衛生防護中心,香港至少新增新冠肺炎確診病例7533例。
此外,大陸地區,山東、四川、遼寧、黑龍江等地相繼出現確診病例。據國家衛健委,2月21日,31個省(自治區、直轄市)和新疆生產建設兵團報告新增確診病例138例。其中境外輸入病例79例,本土病例59例,本土病例包含:內蒙古20例,其中呼和浩特市18例、巴彥淖爾市1例、包頭市1例;江蘇12例,其中蘇州市10例、無錫市2例;遼寧6例,均在葫蘆島市;四川5例,均在成都市;雲南5例,其中德宏傣族景頗族自治州4例、紅河哈尼族彝族自治州1例;北京涉冬(殘)奧閉環人員4例;湖北4例,均在武漢市;廣東3例,均在深圳市。
面對香港疫情的嚴峻,中國工程院院士、著名呼吸病學專家鍾南山表示:“我們不會容忍自然感染導致大量的長者死亡,所以我們的政策仍然是爭取動態清零”。
鍾南山院士還對香港提出三方面的建議,一是預防傳播是關鍵,二是加強疫苗注射,三是儲備藥物治療。
此前,香港特區政府食物及衛生局副祕書長蔡傑銘表示,“疫苗通行證”計劃將從2月24日起實施,市民需要出示疫苗接種記錄後纔可進入商場、街市等場所。第一階段,即4月29日前,12歲以上者需要打一針疫苗纔可入內。
持續更新中》》》
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.